Literature DB >> 6181699

Muscle sarcoplasmic reticulum antigen shared by a Trypanosoma cruzi clone.

M Sadigursky, A M Acosta, C A Santos-Buch.   

Abstract

The results reported here show that a clone of a South American Trypanosoma cruzi human isolate has an epitope antigenically related to sarcoplasmic reticulum adenosine triphosphatase preparations (SRA), an enzyme implicated in the contraction-relaxation cycle of striated muscle. The antigenic determinant of T. cruzi, which is cross-reactive with SRA, is located in the interior of the parasite. No surface cross-reaction was detected with intact, freely swimming flagellates. Indeed, the degree of cross-reactivity was increased when T. cruzi microsomes were trypsinized, probably resulting in further exposure of the normally internal cross-reactive epitope.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6181699     DOI: 10.4269/ajtmh.1982.31.934

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  13 in total

1.  Influence of acute-phase parasite load on pathology, parasitism, and activation of the immune system at the late chronic phase of Chagas' disease.

Authors:  C R Marinho; M R D'Império Lima; M G Grisotto; J M Alvarez
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

2.  A neuraminidase from Trypanosoma cruzi removes sialic acid from the surface of mammalian myocardial and endothelial cells.

Authors:  P Libby; J Alroy; M E Pereira
Journal:  J Clin Invest       Date:  1986-01       Impact factor: 14.808

3.  Major Trypanosoma cruzi antigenic determinant in Chagas' heart disease shares homology with the systemic lupus erythematosus ribosomal P protein epitope.

Authors:  E A Mesri; G Levitus; M Hontebeyrie-Joskowicz; G Dighiero; M H Van Regenmortel; M J Levin
Journal:  J Clin Microbiol       Date:  1990-06       Impact factor: 5.948

4.  Myocardial changes in acute Trypanosoma cruzi infection. Ultrastructural evidence of immune damage and the role of microangiopathy.

Authors:  Z A Andrade; S G Andrade; R Correa; M Sadigursky; V J Ferrans
Journal:  Am J Pathol       Date:  1994-06       Impact factor: 4.307

5.  Circulating antibodies against nicotinic acetylcholine receptors in chagasic patients.

Authors:  J C Goin; G Venera; M Biscoglio de Jiménez Bonino; L Sterin-Borda
Journal:  Clin Exp Immunol       Date:  1997-11       Impact factor: 4.330

6.  A monoclonal antibody with specificity for Trypanosoma cruzi, central and peripheral neurones and glia.

Authors:  D Snary; J E Flint; J N Wood; M T Scott; M D Chapman; J Dodd; T M Jessell; M A Miles
Journal:  Clin Exp Immunol       Date:  1983-12       Impact factor: 4.330

Review 7.  Chagas' disease.

Authors:  H B Tanowitz; L V Kirchhoff; D Simon; S A Morris; L M Weiss; M Wittner
Journal:  Clin Microbiol Rev       Date:  1992-10       Impact factor: 26.132

8.  Enhancement of chronic Trypanosoma cruzi myocarditis in dogs treated with low doses of cyclophosphamide.

Authors:  Z A Andrade; S G Andrade; M Sadigursky
Journal:  Am J Pathol       Date:  1987-06       Impact factor: 4.307

9.  Reversible acquisition of a host cell surface membrane antigen by Trypanosoma cruzi.

Authors:  Q Chess; A M Acosta; J K Sethi; C A Santos-Buch
Journal:  Infect Immun       Date:  1983-04       Impact factor: 3.441

10.  A lytic monoclonal antibody to Trypanosoma cruzi bloodstream trypomastigotes which recognizes an epitope expressed in tissues affected in Chagas' disease.

Authors:  N W Zwirner; E L Malchiodi; M G Chiaramonte; C A Fossati
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.